Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2012
03/14/2012CN102370670A Efficient processing method of Chinese caterpillar fungus
03/14/2012CN102370640A Compound amino acid preparation for hemodialysis and hemodialysis preparation containing same
03/14/2012CN102370628A Tetra-acetylated puerarin self-microemulsified sustained-release double-layer tablet and preparation method thereof
03/14/2012CN102370395A Chinese medicinal health-care pillow and manufacturing method thereof
03/14/2012CN101926869B Medicament for treating dizziness and headache and preparation method thereof
03/14/2012CN101233225B Strain of turkey tail mushroom, extract from the same, and use of the same
03/14/2012CN101098686B Glycogen synthase kinase-3 inhibitors
03/13/2012CA2540529C Means and methods for the recruitment and identification of stem cells
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2435126C Process
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/08/2012WO2012031240A2 Therapeutics for trauma induced factor v consumptive coagulopathy
03/08/2012WO2012031018A1 Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
03/08/2012WO2012031017A1 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012028647A1 Bicyclic aza heterocycles, and use thereof
03/08/2012WO2012028093A1 Use of g-csf dimer in the treatment of neutropenia
03/08/2012WO2012012300A3 Treatment of the adverse side-effects associated with administration of an anti-hyaluronan agent
03/08/2012WO2011150393A9 Methods for improving maternal and fetal health
03/08/2012WO2011130479A3 Application of polymeric materials to screens to facilitate hemostasis and wound healing
03/08/2012WO2011127181A3 System and method for the release of nitric oxide using nanoscale media
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059067 1-acetyl-5-hydroxyanthracene-9,10-dione for treatment of retinal disease
03/08/2012US20120059036 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059012 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/08/2012US20120059010 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058988 Carbazole and carboline kinase inhibitors
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058970 Method and system for reversal of interactions between hydrophobically modified biopolymers and vesicles or cell membranes
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058150 Methods for Delivering Compositions by Electrospraying a Medical Device
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058066 Self-assembling peptide and peptide gel with high strength
03/08/2012CA2810004A1 Crystalline forms of a factor xa inhibitor
03/08/2012CA2809911A1 Bicyclic aza heterocycles, and use thereof
03/07/2012EP2426135A1 Urea derivative having pi3k inhibitory activity
03/07/2012EP2425839A1 Method for treatment of diseases
03/07/2012EP2424847A1 Processes for the preparation of rivaroxaban and intermediates thereof
03/07/2012EP2424571A2 Gene vector
03/07/2012EP2424529A2 Novel therapeutic treatments using centhaquin
03/07/2012EP2424368A1 Pyrrolotriazine compounds
03/07/2012EP1954251B1 Slow-release composition of fe salt as active ingredient, method for the preparation thereof and use of the same
03/07/2012EP1556414B1 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing the same
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN202157038U 一种肝素生产中的原料前期处理装置 One kind of heparin pre-treatment of raw materials in the production of apparatus
03/07/2012CN202157037U 一种肝素分离沉淀装置 One kind of precipitate was isolated by means of heparin
03/07/2012CN102369197A 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as adp receptor antagonists
03/07/2012CN102369020A Novel uses of fibrinogen
03/07/2012CN102367285A Pearsonothuria graeffei fucosylated chondroitin sulfate, extracting method thereof, and purpose thereof
03/07/2012CN102367257A Single-crystal crystal forms of clopidogrel hydrochloride and preparation method and application thereof
03/07/2012CN102367243A Stable potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof
03/07/2012CN102367229A Ethylenediamine diaceturate compound and pharmaceutical composition thereof
03/07/2012CN102366617A Chinese patent medicine for treating idiopathic edema
03/07/2012CN102366616A Chinese medicine for treating idiopathic edema
03/07/2012CN102366556A Medicine for treating cerebral embolism sequela and preparation method thereof
03/07/2012CN102366543A Chinese herbal medicine for treating blood deficiency, blood heat and blood dryness
03/07/2012CN102366538A Blood-enriching and young-keeping traditional Chinese medicine preparation and preparation method thereof
03/07/2012CN102366534A Orally taken traditional Chinese medicinal formula for treating diabetes insipidus
03/07/2012CN102366517A Chinese herbal medicine preparation for preventing and treating qi-blood weakness
03/07/2012CN102366515A Traditional Chinese medicine composition for treating diabetes insipidus
03/07/2012CN102366514A Traditional Chinese medicine preparation with oral administration for treating diabetes insipidus
03/07/2012CN102366506A Traditional Chinese medicine composition for treating idiopathic edema
03/07/2012CN102366483A Traditional Chinese medicine used for treating spleen-kidney yang deficiency
03/07/2012CN102366476A Medicinal liquor for enriching blood and preparation method thereof
03/07/2012CN102366472A Chinese herbal medicine for treating excessive bleeding and qi deficiency
03/07/2012CN102366450A Regeneration soup of dragon and deer and purpose thereof
03/07/2012CN102366436A Miao medicament for treating liver diseases and ascites
03/07/2012CN102366410A Argatroban liposome injection
03/07/2012CN102366317A Eye-protection wet tissue
03/07/2012CN101390986B Traditional Chinese medicine composition for cerebral thrombus and preparation method thereof
03/07/2012CN101306026B Natural indigo prepared by froth flotation method and its preparation method and device
03/06/2012US8129541 5-phenylthiazole derivatives and use as PI3 kinase inhibitors
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
03/06/2012US8129373 Carbonyl compounds
03/06/2012US8129343 Acylated GLP-1 compounds
03/06/2012US8129339 Microencapsulation and sustained release of biologically active polypeptides
03/06/2012CA2699627C Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
03/01/2012WO2012027543A1 Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
03/01/2012WO2012025942A1 Methods for the treatment or prophylaxis of thrombosis or embolism
03/01/2012US20120053619 Hemostatic compositions and methods of making and using same
03/01/2012US20120053451 Methods and systems for prolonged localization of drug delivery
03/01/2012US20120053235 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders
03/01/2012US20120053218 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
03/01/2012US20120053214 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 671